Machine learning prioritizes ruthenium complexes with increased MRSA antibacterial hit rates
Researchers trained machine-learning models on 288 modularly synthesized ruthenium arene Schiff-base complexes and used them to prioritize 54 new compounds for antibacterial-activity testing. The model-selected set had a 53.7% hit rate against methicillin-resistant Staphylococcus aureus, compared with 9.4% in the original library, an approximately 5.7-fold enrichment.
Technology: Machine-learning activity-prediction models trained on ruthenium arene Schiff-base complex structures and antibacterial assay data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Researchers trained machine-learning models on 288 modularly synthesized ruthenium arene Schiff-base complexes and used them to prioritize 54 new compounds for antibacterial-activity testing.
- Still unknown: This is a study-specific in-vitro antibacterial hit-rate enrichment, not animal efficacy, clinical validation, or an approved antibiotic. The comparison is 54 model-selected compounds vs the 288-complex source library, not a randomized prospective comparison with all possible metal complexes.
- AI role: Models were trained using assay data from 288 modularly synthesized ruthenium complexes and used to predict activity for a new set of 54 compounds. Those prioritized compounds were then assessed for antibacterial activity; the paper reports higher MRSA hit-rate in the model-selected set than in the original library.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38088924/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 50 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.